Skip to main content
Signal8

Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic

$NWBOPress releaseApr 21, 2026, 9:30 AM ETRead the release

Northwest Biotherapeutics is establishing a dedicated leukapheresis clinic at The London Welbeck Hospital to proactively address capacity constraints and support the scale-up of its DCVax programs. The facility is designed to handle 4 patients per day with built-in flexibility for extended hours and weekend operations, with buildout expected to finish by June.

Key figures

Daily capacity patients
4
Buildout completion month
June

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    NWBO: Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic — AI Analysis | Signal8